Spending investment dollars on compliance can limit R&D and delay R&D so changes like the on-ramp, Congressman Fitzpatrick's legislation, and Congressman Hurt's audit firm rotation bill are important for growing biotechs without product revenue.
Emphasizing the importance of legislative changes for biotech R&D funding.
Share
More from Michael Fitzpatrick
The protection of our personal data is increasingly a critical part of our private lives, and the threat of data breaches from state or non-state actors looms heavy over security experts in nearly every sector of the American economy.
This week, it is the United States Department of Housing and Urban Development, whose own Inspector General found evidence that senior employees may have circumvented the hiring process to appoint politically connected lobbyists to…
If they see justice being served at least in another jurisdiction, even if not in their own, that will be very encouraging to them.
Other voices in this conversation
